Ron Squarer – Biography
Last update: 15 days agoExecutive profile
Ron was Director at Retrophin, and Director and Chief Executive Officer at Array BioPharma. Ron Squarer joined Travere Therapeutics in 2025.
Ron Squarer is currentlyChairman of the Board at ADC Therapeutics - View - ADC Therapeutics org chart
Director at Nuvalent - View - Nuvalent org chart
Director at Travere Therapeutics - View - Travere Therapeutics org chart
Create your alert
to follow the career of Ron Squarer.
Education
Ron Squarer graduated from University of California, Berkeley and from Northwestern University - Kellogg School of Management.
They have also studied at University of California, Berkeley :
Find more alumni from University of California, Berkeley
They have also studied at Northwestern University - Kellogg School of Management :
Find more alumni from Northwestern University - Kellogg School of Management
More about Ron Squarer
Selected links
Do you need to know more about Ron Squarer? More results.
Participate
Social media
- Ron Squarer on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Ron Squarer
The colleagues of Ron Squarer
Company Colleagues
- At ADC Therapeutics, Ron Squarer has 18 colleagues including Ameet Mallik (CEO), Tyrell Rivers (Director)…
- At Nuvalent, Ron Squarer has 50 colleagues including James Porter (CEO), Anna Protopapas (Chairman of the Board)…
- At Travere Therapeutics, Ron Squarer has 33 colleagues including Eric Dube (CEO & Director), Jeffrey Meckler (Director)…
Industry Colleagues
- In the Biotechnology industry, Ron Squarer has 35,909 colleagues in 2,415 companies located in 43 countries. 17,045 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Ron Squarer.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Ron Squarer.
